FMO5 and chronic granulomatous disease: Consistent with the crucial role of the NADPH oxidase in phagocyte killing and the heightened susceptibility of NADPH oxidase-deficient mice to invasive candidiasis [8], [12], patients with chronic granulomatous disease are at increased risk for development of the infection [26].